Weighting must wait: Incorporating equity concerns into cost-effectiveness analysis may take longer than expected

PharmacoEconomics

Volumn 27, Issue 12, 2009, Pages 983-989

  Wailoo, Allan ^a   Tsuchiya, Aki ^a,b   McCabe, Christopher ^c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DECISION MAKING; ECONOMIC EVALUATION; HEALTH INSURANCE; NOTE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RESOURCE ALLOCATION;

COMPARATIVE EFFECTIVENESS RESEARCH; COST-BENEFIT ANALYSIS; DECISION MAKING; ECONOMICS, MEDICAL; HEALTH POLICY; POLICY MAKING; SOCIAL JUSTICE;

EID: 73549117006     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/11314100-000000000-00000     Document Type: Note

References (15)

1. Drummond M, McGuire A, editors. Economic evaluation in health care. Oxford: Oxford University Press, 2001
2. PHARMAC Pharmaceutical Management Agency. Decision criteria [online]. Available fromURL: http://www.pharmac. govt.nz/patients/DecisionMakingProcess/ DecisionCriteria [Accessed 2009 Mar 24]
3. NICE. Social value judgements: principles for the development of NICE guidance. London: NICE, 2007
4. Schwappach D. Resource allocation, social values and the QALY: a review of the debate and empirical evidence. Health Expect 2002; 5: 210-212
5. Dolan P, Shaw R, Tsuchiya A, et al. QALY maximisation and people's preferences: a methodological review of the literature. Health Econ 2005; 14: 197-208
6. Dolan P, Tsuchiya A. The elicitation of distributional judgements in the context of economic evaluation. In: Jones A, editor. Companion to health economics. Cheltenham: Edward Elgar, 2006
7. Wagstaff A. QALYs and the equity-efficiency trade off [published erratum appears in J Health Econ 1993; 12 (2): 237]. J Health Econ 1991; 10 (1): 21-41
8. Williams A. Intergenerational equity: an exploration of the 'fair innings' argument. Health Econ 1997; 6: 117-132
9. Nord E, Pinto JL, Richardson J, et al. Incorporating societal concerns for fairness in numerical valuations of health programmes. Health Econ 1999; 8: 25-39
10. Dolan P, Olsen JA. Desperately seeking numbers: the notso- holy grail of the 'super QALY' [abstract]. 20th Nordic HESG; 1999 Aug 20-21; Reykjavik
11. Dowie J. Towards the equitably efficient and transparently decidable use of public funds in the deep blue millennium. Health Econ 1998; 7: 93-103
12. Johnson P, Falkingham J. Ageing and economic welfare. London: Sage, 1992
13. Office for National Statistics. 2008 Trends in life expectancy by social class 1972-2005 [online]. Available from URL: http://www.statistics.gov.uk/ downloads/theme-population/ Life-Expect-Social-class-1972-05/life-expect-social- class. pdf [Accessed 2008 Apr 30]
14. Barrett A, Roques T, Small M, et al. Rationing: how much will herceptin really cost? BMJ 2006; 333: 1118-1120
15. Williams A, Cookson R. Equity in health. In: Culyer AJ, Newhouse JP, editors. Handbook of health economics. Vol.1b. Amsterdam: Elsevier, 2000